NEDD4-2 (NEDD4L), a ubiquitin protein ligase of the Nedd4 family, is a key regulator of cell surface expression and activity of the amiloride-sensitive epithelial Na + channel (ENaC). While hypomorphic alleles of Nedd4-2 in mice show salt-sensitive hypertension, complete knockout results in pulmonary distress and perinatal lethality due to increased cell surface levels of ENaC. We now show that Nedd4-2 deficiency in mice also results in an unexpected progressive kidney injury phenotype associated with elevated ENaC and Na + Cl − cotransporter expression, increased Na + reabsorption, hypertension and markedly reduced levels of aldosterone. The observed nephropathy is characterized by fibrosis, tubule epithelial cell apoptosis, dilated/cystic tubules, elevated expression of kidney injury markers and immune cell infiltration, characteristics reminiscent of human chronic kidney disease. Importantly, we demonstrate that the extent of kidney injury can be partially therapeutically ameliorated in mice with nephron-specific deletions of Nedd4-2 by blocking ENaC with amiloride. These results suggest that increased Na + reabsorption via ENaC causes kidney injury and establish a novel role of NEDD4-2 in preventing Na + -induced nephropathy. Contrary to some recent reports, our data also indicate that ENaC is the primary in vivo target of NEDD4-2 and that Nedd4-2 deletion is associated with hypertension on a normal Na + diet. These findings provide further insight into the critical function of NEDD4-2 in renal pathophysiology.
Na + homeostasis in the kidney is critical for the maintenance of blood volume and blood pressure (BP). The Na + reabsorption in the nephron is mediated via the Na + Cl − co-transporter (NCC) in the distal convoluted tubule (DCT), and through the amiloride-sensitive epithelial Na + channel (ENaC) in the connecting tubule (CNT), distal tubule (DCT) and the collecting duct (CD). Both NCC and ENaC are regulated by the ubiquitin protein ligase, NEDD4-2. [1] [2] [3] [4] [5] Although NEDD4-2 is known to ubiquitinate and regulate the expression of many cell surface proteins, the most studied targets of NEDD4-2 are the three subunits (α, β and γ) of ENaC. The WW domains of NEDD4-2 have been demonstrated to directly bind to the PPxY motifs present in the cytoplasmic C termini of all three ENaC subunits leading to their ubiquitination, endocytosis and degradation. 2, 3 Thus, an expected consequence of the loss of Nedd4-2 is increased cell surface expression and membrane retention of ENaC, resulting in increased ENaC activity. 1 The significance of NEDD4-2-dependent regulation of ENaC in the maintenance of Na + homeostasis is apparent from Liddle's syndrome, characterized by constitutively elevated ENaC activity and hypertension due to mutations in the PY motifs of βand γ-ENaC, which abrogate the interaction between ENaC and NEDD4-2. 2 NEDD4-2 is widely expressed during mouse development and in adult tissues, with particularly high expression in the liver, kidney, heart, brain and lung. 1, 6 The studies of Nedd4-2 knockout (KO) mice have provided useful and also somewhat unexpected and contradictory insights into the in vivo function of NEDD4-2. A Nedd4-2 KO mouse line (Nedd4-2 Δ exons 6-8, which includes an alternative translation start site and WW domain 1) express small amounts of Nedd4-2 splicing isoforms. 7 These mice appear normal but show slightly increased ENaC expression and hypertension upon feeding a high-salt diet. 7 A renal-tubule-specific Nedd4-2 conditional KO mouse with the same mutation (Nedd4L Pax8/LC1 ) demonstrated that hypertension is largely due to increased expression and activity of the NCC. 8 Recently, it was shown that α and γ (but not β) ENaC levels are increased when these mice are fed a long-term, low K + diet. 9 A KO line generated in our laboratory in which all Nedd4-2 splicing variants are absent (Nedd4-2 Δ exons 15-16) display increased ENaC expression in the lung and kidney, with perinatal death of animals due to respiratory distress as a result of failure of lungs to inflate, or severe sterile inflammation of the lung. 5 The different severity of the phenotypes between these lines is likely due to the hypomorphic nature of the Nedd4-2 Δ exons 6-8 allele. This is supported by studies with another independent line where Nedd4-2 KO results in perinatal death, 10 and a conditional KO of Nedd4-2 in the lung that was found to be sufficient for animals to develop inflammatory lung disease, leading to perinatal lethality. 10 To determine the effect of Nedd4-2 loss in the kidney, we analyzed the pathology of Nedd4-2 Δ exons 15-16 mice. We report here that Nedd4-2 loss results in progressive kidney damage beginning immediately after birth. Additionally, we confirm this pathology in a kidney tubule-specific Nedd4-2 KO mouse line, Nedd4-2 Ksp1. 3 . We further show that increased ENaC activity contributes to the observed kidney damage.
We therefore provide the first evidence that loss of Nedd4-2 results in early and progressive kidney damage. Given our demonstration of a direct and critical role for ENaC in renal injury, our Nedd4-2 KO mice can be a valuable resource for the study of the effects of salt on progression of kidney damage.
Results
Nedd4-2 −/− kidney pathology consistent with kidney damage. We have previously described a perinatal lethal phenotype of Nedd4-2 −/− mice due to respiratory distress; however, a small percentage of animals survive up to 3 weeks of age. 5 To determine the role of NEDD4-2 in the kidney, we carried out pathological analysis of kidneys from wild-type and surviving Nedd4-2 −/− mice at postnatal (P) day 20. Kidneys from Nedd4-2 −/− mice appeared pale and showed histological changes consistent with renal damage, including a disorganized structure and numerous cortical cysts with necrotic cellular debris, often with luminal stenosis/obstruction ( Figure 1a ). Large areas of mesenchyme were observed by histology, immunohistochemistry and real-time quantitative PCR (qRT-PCR) for the mesenchymal marker, vimentin (Figures 1b and c ). In addition, Nedd4-2 −/− kidneys showed obvious fibrotic damage occupying a large portion of the cortex revealed by immunohistochemistry and qRT-PCR for α-1 type 1 collagen. Consistent with kidney injury, expression of the myofibroblast marker, α-smooth muscle actin (SMA), and marker for proximal tubule kidney injury, kidney injury molecule-1 (KIM-1, also referred to as T-cell immunoglobulin mucin (TIM-1), 11 was upregulated in Nedd4-2 −/− kidneys compared with wild type at P20 (Figures 1b and c) .
Time-course analysis revealed normal kidney histology at embryonic day (E) 18.5, with damage becoming evident by P3 and progressing in severity until death at~P20 (Supplementary Figure 1 ). The lack of kidney pathology at E18.5 suggests that kidney development occurs normally in Nedd4-2-deficient mice.
Generation of renal-tubule-specific Nedd4-2-deficient mice. After identifying a critical new role for NEDD4-2 in renal homeostasis, we next aimed to investigate the progression of kidney injury beyond 20 days. To this end, we generated a renal-tubule-specific Nedd4-2 KO mouse line by crossing a previously generated Nedd4-2 fl/fl mouse line (with ablation of Nedd4-2 exon 15 onward, resulting in the absence of the catalytic HECT domain and a complete loss of Nedd4-2 protein) 10 to the Ksp1.3-Cre transgene line. 12 Ksp-cadherin, also called cadherin-16, has a well-characterized, kidney-specific expression in renal epithelial cells of the collecting ducts, loop of Henle, the majority of proximal tubules and in some distal tubules. 13 Therefore, Ksp1.3-Cre; Nedd4-2 fl/fl blocks NEDD4-2 expression in cadherin-16positive cells and is hereafter referred to as Nedd4-2 Ksp1.3 . Immunoblot analysis of whole kidney lysates from this strain showed a decrease in NEDD4-2 protein compared with control kidneys (Cre negative) at P40 (Figure 2a ). This was quantitated to an average reduction of~50% ( Figure 2b ).
Remaining NEDD4-2 is likely due to expression within the glomerulus, blood vessels and any other cells that do not express cadherin-16, but express NEDD4-2. 12, 13 Immunohistochemical staining of control kidneys demonstrated high NEDD4-2 expression within the distal nephron including the collecting ducts, indicated by overlapping expression with the lectin marker, dolichos biflorus agglutinin (DBA) ( Figure 2c ). Importantly, NEDD4-2 expression was completely abolished in the distal renal tubule of Nedd4-2 Ksp1.3 kidneys.
Nedd4-2 ablation in renal tubules leads to renal pathology. Nedd4-2 Ksp1.3 revealed a similar progressive renal pathology to the global Nedd4-2 −/− mice, with a slightly later onset. Macroscopic analysis revealed only minor differences between control and Nedd4-2 Ksp1.3 kidneys at P20 progressing to mild changes at P40 evident by an irregular border and small areas of disorganized tissue (Figure 3a ). At 6 months, the kidneys appeared pale with small cysts in the cortex and a hydronephrotic renal pelvis. Histological staining showed increased tissue disorganization, tubule enlargement and fibrosis, starting from small isolated regions at P20 to larger fibrotic regions radiating in from the cortex at 6 months ( Figure 3b ). Closer analysis of Nedd4-2 Ksp1.3 mice at P40 showed enlarged tubules, with thinning or hypercellular epithelium, necrotic cellular debris and significant collagen deposition throughout the cortex and medulla as visualized Nedd4-2 deficiency leads to increased expression of ENaC and NCC. We next wanted to determine whether the levels of ENaC and NCC are altered in Nedd4-2 Ksp1.3 kidneys and could contribute to the renal disease observed in Nedd4-2-deficient animals. During the process of maturation, all three subunits of ENaC (α, β and γ) are post-translationally modified. The α and γ subunits are processed by proteolytic cleavage to their mature forms, and the β-subunit undergoes glycoprotein processing. 14, 15 It is the mature ENaC complexes that are predominantly localized at the plasma membrane where they are regulated by NEDD4-2. 16 Increased BP and salt reabsorption in Nedd4-2 Ksp1.3 mice. Nedd4-2 Ksp1.3 mice had increased blood Na + concentration, reduced blood K + concentration and increased K + excretion on a standard laboratory diet (Table 1) , which has not been previously observed in other Nedd4-2 KO models, even on a high-salt diet. 7, 8 Nedd4-2 Ksp1.3 mice also produced more urine with a significantly lower osmolarity than their control counterparts, possibly as a result of the increased Na + reabsorption. Glomerular filtration rate (GFR) at 6 months was unchanged compared with controls. Importantly, diastolic (DBP) and systolic BP (SBP) were significantly higher in Nedd4-2 Ksp1.3 mice and blood aldosterone levels were reduced ( Figure 6 ). Aldosterone has a central role in Na + conservation in the body and is regulated by the blood serum levels of K + and inversely by the levels of Na + . Low aldosterone levels therefore indicate increased Na + /reduced K + retention in Nedd4-2 Ksp1.3 mice even on a normal laboratory diet. Taken together, these results demonstrate the critical role of NEDD4-2 in regulating Na + and K + levels in the blood.
Kidney damage is reduced by inhibition of ENaC. To determine if ENaC and NCC could give rise to the kidney damage, we treated mice with either amiloride (a specific inhibitor of ENaC) or hydrochlorothiazide (HCTZ; to block NCC) from P20 (weaning) until P41 (Figure 7a ). Blood aldosterone was significantly increased upon treatment with amiloride in both controls and Nedd4-2 Ksp1.3 mice (Figure 7b ), correlating with the expected effects of amiloride These data suggest that inhibiting ENaC activity with amiloride was able to alleviate the disease phenotype. On the contrary, HCTZ treatment had little beneficial effect in alleviating the kidney pathology. These results were supported by immunostaining for KIM-1 (Figures 7e and f) . Taken together, these data demonstrate for the first time that a lack of NEDD4-2 increases Na + reabsorption through increased expression and activity of ENaC, and that this results in kidney damage as well as hypertension on a standard laboratory diet. 
Discussion
In this study, we have identified a novel link between Nedd4-2 deficiency and nephropathy. We report for the first time that deletion of Nedd4-2 in the kidney results in a progressive kidney pathology characterized by renal fibrosis, cortical cysts, inflammation and tubular epithelial cell apoptosis. We have shown that this pathology critically involves Absence of Nedd4-2 results in kidney damage. As described previously, most Nedd4-2 −/− mice die perinatally from respiratory distress. 5 However, the few Nedd4-2 −/− mice that survive display progressive kidney damage developing shortly after birth, with pathological features similar to those commonly observed in patients with nephropathies, such as fibrosis, cortical cysts, enlarged tubules and cellular casts. 17 Given the early postnatal lethality of Nedd4-2 −/− mice, we generated a renal-tubule-specific line (Nedd4-2 Hypertension is known to contribute to kidney damage and CKD. 18 In both Nedd4-2 −/− and Nedd4-2 Ksp1.3 mice, kidney damage begins soon after birth indicating that this pathology is unlikely to be a secondary effect of hypertension. Furthermore, additional models of Nedd4-2 deletion, which exhibit a similar degree of hypertension, display no evidence of kidney damage. 7, 8 These data suggest that the kidney pathology observed in Nedd4-2 KO mice is due to a primary effect on the tubular epithelia rather than as a result of hypertension.
Kidney pathology caused by increased ENaC expression. Importantly, our Nedd4-2 KO mice develop kidney damage on a standard laboratory diet, and the increased Na + reabsorption appears to be due, at least in part, to increased levels of ENaC on the plasma membrane. Indeed, we observed greater expression of the active forms of all three ENaC subunits in the collecting ducts of Nedd4-2 Ksp1.3 kidneys. In addition, we also observed a significant increase in levels of NCC, which was noted in the Nedd4L Pax8/LC1 model. 8 The discrepancy in ENaC expression levels between different Nedd4-2 mutant mouse models can be explained by some expression of functional Nedd4-2 splice variants in other Nedd4-2 mutant mouse lines. 5 In our Nedd4-2 Ksp1.3 mice, no functional NEDD4-2 can be expressed given that the HECT domain is targeted.
The significance of increased levels of active ENaC in the development of kidney disease in Nedd4-2 Ksp1.3 mice is clear from our data showing that amiloride treatment reduces renal damage. Thus, increased functional ENaC at the plasma membrane appears to be a contributing factor to the development of kidney disease. Indeed, ENaC has been implicated in the development of kidney damage in Dahl salt-sensitive rats that develop hypertension and renal damage after 4 weeks on a high-salt diet. 19, 20 In our Nedd4-2 Ksp1.3 mice, inhibition of NCC alone (with HCTZ) was not able to rescue the disease phenotype in our Nedd4-2 Ksp1.3 mice, suggesting that ENaC, and not NCC, is a major contributor to the disease. Administration of amiloride, however, did not fully rescue the kidney damage seen in Nedd4-2 Ksp1.3 mice. We therefore hypothesize that in addition to increased Na + absorption by ENaC, other NEDD4-2regulated mechanisms may contribute to the renal pathology seen in Nedd4-2-deficient animals.
Clinical significance of NEDD4-2 in salt induced kidney damage. The effect of Nedd4-2 deficiency in renal pathology has not been previously characterized. There is Nedd4-2 prevents kidney damage TL Henshall et al evidence that Nedd4-2 contributes to salt-sensitive hypertension in humans, as multiple single-nucleotide polymorphisms (SNPs) in this gene have been linked to increased ENaC expression and hypertension. [21] [22] [23] [24] [25] However, their possible role in kidney disease has not been reported. In a previous study assessing NEDD4L variants in hypertension, two patients with a nonsynonymous variant of NEDD4L were also found to have end-stage renal disease (ESRD). 26 Thus, SNPs of NEDD4L can lead to hypertension, as well as contribute to renal diseases in patients, similar to that observed in the Nedd4-2 −/− and Nedd4-2 Ksp1.3 mice.
Conclusions
Approximately 1 in 10 people worldwide suffer from varying degrees of CKD, and those with hypertension or diabetes are at even higher risk. 27 In addition, CKD can itself contribute to hypertension and cardiovascular disease further fueling the burden of CKD on healthcare systems worldwide. 28 Acute kidney injury can initiate the onset of chronic and ESRD 29, 30 and is therefore an important focus for early intervention to limit kidney pathology. NEDD4-2 is a critical regulator of Na + ion channels along the nephron, and polymorphisms in the human NEDD4L gene are associated with salt-sensitive hypertension and kidney disease. This makes NEDD4-2, and proteins that may regulate it, important targets for the development of therapeutics for improved health care of patients with kidney disease. The studies reported here provide new data toward the understanding of the function of NEDD4-2, its critical role in Na + homeostasis, and the contribution of increased Na + reabsorption to renal disease.
Materials and Methods
Mouse lines. Global Nedd4-2 −/− mice were generated in our laboratory previously. 5 Kidney-specific inactivation of Nedd4-2 was achieved by crossing the Nedd4-2-floxed line (Nedd4-2 fl/fl ) 10 with the Ksp-Cre transgenic strain from Peter Igarashi's laboratory (obtained through Christina Mitchell). 12 Homozygous Nedd4-2floxed mice (Nedd4-2 fl/fl ) were crossed with heterozygous mice expressing the Ksp1.3-Cre transgene. From the filial (F) 1 progeny, litters with heterozygous deletion of Nedd4-2 gene that harbored the Ksp1.3-Cre transgene (Ksp1.3-Cre; Nedd4-2 fl/+ ) were selected and further crossed with Nedd4-2 fl/fl mice to obtain mice expressing complete deletion of Nedd4-2 in the F2 progeny (Ksp1.3-Cre; Nedd4-2 fl/fl ), referred to as Nedd4-2 Ksp1.3 mice. Nedd4-2 −/− (C57BL/6 J) and Nedd4-2 Ksp1.3 (C57BL/6 J) mice were bred at the SA Pathology Animal Facility (Adelaide, Australia) under specific pathogen-free conditions. All animal studies were approved by the institutional animal ethics and biosafety committees at SA Pathology, and were carried out according to the National Health and Medical Research Council guidelines.
For tissue collection, mice were anesthetized and blood collected by cardiac puncture. Animals were then quickly killed by cervical dislocation. Kidneys were removed and the fibrous capsule dissected off. One kidney was snap frozen in liquid nitrogen, and the other was cut in half in the coronal plane and immersion fixed in Histochoice (ProSciTech, Kirwan, QLD, Australia) for 48 h at 4°C. One-half of the kidney was paraffin embedded and the other half was embedded in OCT for frozen sections.
Drug treatment studies. For drug treatment studies, mice were treated with amiloride (Sigma-Aldrich, St. Louis, MO, USA; 2 mg/kg per day: 14 mg/l) 31 or HCTZ (Sigma-Aldrich; 10 mg/kg per day: 67 mg/l) 32 in the drinking water. Treatment began after weaning at P20, with water changed daily for 21 days. Animals were anesthetized for blood and tissue collection as above. During treatment, mice were group housed in standard conditions with free access to food and water and monitored daily.
Metabolic cage studies. Male, 6-month-old Nedd4-2 Ksp1.3 and control littermates were housed in metabolic cages for 24 h following three training sessions of 6 h each. Mice were provided ad libitum access to deionized drinking water and standard pelleted chow, and urine was collected every 5 h. At the end of the experiment, blood and tissue samples were taken as described above.
Histological analysis. Kidney tissues fixed in histochoice were embedded in paraffin and 5-μm sections were cut using a paraffin microtome. The sections were mounted on glass slides, deparaffinized with xylene, dehydrated through graded series of ethanol and stained with hematoxylin-eosin. To evaluate collagen deposition using picrosirius red, slides were stained for 1 h in saturated picric acid with 0.1% Direct Red 80 (Sigma-Aldrich), and then washed in 0.01 N hydrochloric acid for 2 min. Digital images were acquired by using a NanoZoomer Imager (Hamamatsu Photonics K. K., Japan).
Antibodies and immunohistochemistry. Paraffin sections (5 μm) were deparaffinized and hydrated in a graded ethanol series. Heat-mediated antigen retrieval was carried out by boiling for 10 min in 10 mM citric acid solution (pH 6). Tissue sections were blocked with 10% goat serum. Primary antibodies used were: rabbit anti-αENaC and rabbit anti-γENaC; 33 rabbit anti-βENaC; 5 fluoresceinconjugated Lotus tetragonolobus agglutinin (cat. no. FL-1321; Vector Laboratories, Burlingame, CA, USA); rhodamine-labeled DBA (cat. no. RL-1032; Vector Laboratories); FITC-conjugated mouse anti-SMA (cat. no. F3777; Sigma-Aldrich); rabbit anti-vimentin (cat. no. ab92547; Abcam, Cambridge, UK); rabbit anti-NCC (cat. no. ab3553; Abcam); rabbit anti-cleaved caspase-3 (cat. no. 9661 S; Cell signaling Technologies, Danvers, MA, USA); rat anti-Kim-1 (cat. no. MAB1817; R&D Systems, Minneapolis, MN, USA). Immunostainings for Kim-1 and all ENaC subunits were carried out on frozen sections (14 μm). For colorimetric staining, endogenous peroxidase was blocked by incubation in 3% hydrogen peroxide before primary antibody addition, sections were incubated with the corresponding biotinylated secondary antibodies and sequentially incubated in ABC-Peroxidase Solution according to the manufacturer's protocol (Thermo Fisher Scientific, Waltham, MA, USA), before being developed with 3,3′-diaminobenzidine (DAB; Sigma-Aldrich). Sections were lightly counterstained with hematoxylin, and then dehydrated and mounted. For fluorescence staining, tissue sections were incubated with the corresponding fluorescently tagged secondary antibodies (AlexaFluor-488 or -568; Thermo Fisher Scientific), counterstained with DAPI and mounted in Prolong Gold Antifade reagent (Thermo Fisher Scientific). Stained samples were imaged using an LSM 700 confocal microscope using Zen 2011 (Black Edition) version 8.1.5.484 (Carl Zeiss Microscopy, Jena, Germany) or Nanozoomer Imager (Hamamatsu Photonics K. K., Japan). Image analysis was carried out using ImageJ (NIH, Bethesda, MD, USA), Photoshop and Adobe Image Suite (Adobe, San Jose, CA, USA) Software.
Quantification. Cleaved caspase-3-positive or CD3-positive cells were counted in eight random cortical fields from four kidneys of each genotype at x20 magnification. Quantitation of total fluorescence from NCC-positive cells was carried out from 4-6 random fields in the cortex of three mice each for control and Nedd4-2 Ksp1.3 kidneys at x100 magnification. Total fluorescence levels for each image was measured using ImageJ (NIH). Percentage area of Kim-1-positive staining was measured in the cortex and medulla of drug-treated and -untreated mice. Frozen sections (14 μm) from at least six mice per group were immunostained for Kim-1 and then developed using DAB. Each section was then imaged on the Nanozoomer Imager and the percentage area of Kim-1 staining in the cortex and medulla was quantitated using ImageJ (NIH).
Immunoblotting. Kidneys were lysed in ice-cold extraction buffer at pH 7.5 (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.27 M sucrose, 0.1% β-mercaptoethanol and HALT protease and phosphatase inhibitor cocktail; Thermo Fisher Scientific). Tissue was homogenized, frozen in liquid nitrogen, immediately thawed and incubated at 4°C on a nutator for 30 min and centrifuged at 13 000 r.p. m. for 5 min. Supernatant protein (100 μg) was combined with protein load buffer (100 mM Tris-HCl, pH 6.8, 200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol), heated at 95°C for 5 min, loaded onto 4-20% precast SDS-PAGE gels (Bio-Rad, Hercules, CA, USA) and transferred to PVDF membrane using the Transblot Turbo Instrument (Bio-Rad). Membranes were blocked with 1% skim milk in TBS-T (Tris-buffered saline/0.05% Tween-20) and primary antibodies were added: rabbit anti-Nedd4-2, 34 mouse anti-β-actin (clone AC15; Sigma-Aldrich), or ENaC and NCC antibodies described above. HRP secondary antibodies were added
